GlassScriptPhysician profile
David Shieh
NPI 1740741701
$2,861.77
in general payments reported to CMS, 2019-2025
16 companies · $440 in 2025
The $440 reported for 2025 was less than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $113 · 2021: $270 · 2022: $727 · 2023: $876 · 2024: $435 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,462 · Travel and Lodging: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,462.45 |
| Travel and Lodging | $288.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $952.80 | 2020-2023 | Constellation |
| Bausch & Lomb Americas INC. | $374.28 | 2024 | Stellaris, Totalvisc, Envista Mx60 Iol |
| Apellis Pharmaceuticals, INC. | $295.94 | 2023-2025 | Syfovre |
| Glaukos Corporation | $262.99 | 2022-2023 | |
| Genentech USA, INC. | $242.03 | 2022-2025 | Vabysmo |
| Abbvie INC. | $173.95 | 2022-2025 | |
| Regeneron Pharmaceuticals, INC. | $125.00 | 2021 | |
| Ivantis, INC | $121.26 | 2021 | |
| Allergan, INC. | $99.99 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $80.58 | 2025 | Eylea Hd |
| Ani Pharmaceuticals, INC. | $34.48 | 2025 | Iluvien |
| Oyster Point Pharma, INC. | $25.93 | 2023 | Tyrvaya |
| Horizon Therapeutics Plc | $24.05 | 2021 | |
| Neurotech Pharmaceuticals, INC. | $20.79 | 2025 | |
| Harrow Eye, LLC | $19.40 | 2025 | Iheezo |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $8.30 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Shieh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.